IL18BP and dilated cardiomyopathy: The protective effects of IL-18BP were lost in the failing heart—myocardial IL-18BP mRNA expression was significantly downregulated in both ischemic (0.25 ± 0.05, p < 0.0001) and dilatative cardiomyopathy (0.18 ± 0.02, p < 0.0001) [97].